In line with this, Chen and his colleagues reported that GC patients with higher immune score and higher abundance of CD8+ T cells, CD4+ T–activated cells, follicular helper T cells, M1 macrophages, and NK cells had better prognosis [49]. This evidence concerns the gene CD4 and gastric cancer.